Related Experiment Video

Updated: Jul 5, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Heart transplantation after congenital heart surgery: improving results and future goals

Jacob Simmonds1, Michael Burch, Helen Dawkins

  • 1Great Ormond Street Hospital for Children, London, UK.

European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|May 27, 2008
PubMed

Insights

Pediatric heart transplantation for complex congenital heart disease (CHD) is increasingly common. Outcomes are improving, narrowing the gap compared to cardiomyopathy patients, offering hope for improved long-term cardiac function.

Area of Science:

  • Cardiology
  • Pediatric Cardiac Surgery
  • Transplantation Medicine

Background:

  • Increasing survival of complex congenital heart disease (CHD) leads to more patients requiring cardiac failure management in later life.
  • This trend places a significant burden on transplant centers and the limited donor heart supply.
  • Historically, heart transplant outcomes for CHD were poorer than for cardiomyopathy.

Purpose of the Study:

  • To review current heart transplantation protocols for patients with congenital heart disease.
  • To present a 20-year single-center experience with heart transplantation in this population.
  • To discuss potential future advancements in the field of CHD heart transplantation.

Main Methods:

  • Retrospective analysis of a single-center's heart transplant data over 20 years.
  • Review of current transplantation protocols for congenital heart disease patients.
  • Comparison of outcomes between CHD and cardiomyopathy etiologies.

Main Results:

  • Surgical experience and intensive care advancements are improving outcomes for CHD heart transplants.
  • The disparity in outcomes between CHD and cardiomyopathy is decreasing.
  • Data from a large single-center experience over two decades is presented.

Conclusions:

  • Heart transplantation is a viable option for select patients with end-stage congenital heart disease.
  • Ongoing improvements in surgical and critical care are enhancing transplant success rates.
  • Further research and innovation are needed to address the challenges in this complex field.

More Related Videos

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents06:33

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents

Published on: September 21, 2021

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment08:49

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...